Opinion Putting cosmeceuticals in context ‘Handbook of cosmeceutical excipients and their safeties’, by Kwan Yu Heng, Tung Yee Kei, Kochhar Jaspreet Singh, Li Hairui, Poh Ai-Ling and Kang Lifeng.…Published: 12 February 2015
News First-in-class oral drug approved for psoriasis conditions in Europe The European Commission has authorised apremilast (Celgene’s Otezla), a first-in-class oral drug for the treatment of chronic plaque psoriasis and psoriatic arthritis in patients who have failed first-line systemic therapies.…Published: 30 January 2015
Opinion Top 10 learning articles of 2014 from The Pharmaceutical Journal Our response to the Ebola outbreak is a sign of how our learning content is changing to meet your needs.…Published: 20 January 2015
Opinion Illustrating disease in the 19th century ‘The Sick Rose or; Disease and the art of medical illustration’, by Richard Barnett.…Published: 2 January 2015
News NSAIDs may help protect against skin cancer The use of non-steroidal anti-inflammatory drugs (NSAIDs), a class of medicines used to treat pain and inflammation, is associated with a reduced risk of developing cutaneous squamous cell carcinoma (SCC), a type of skin cancer, research suggests.…Published: 22 December 2014
Feature Immune checkpoint inhibitors bring new hope to cancer patients PD-1 and PD-L1 inhibitors induce a higher response rate across a wider range of tumours than other immunotherapies.…Published: 18 November 2014
News Diabetic wounds heal faster with deferoxamine patch Researchers have developed a transdermal patch that delivers the small molecule deferoxamine to accelerate wound healing in diabetes.…Published: 3 November 2014
News First drug for rare sun disease recommended for approval in Europe The European Medicines Agency recommends that Scenesse (afamelanotide) should be approved for the prevention of severe sunburn in patients with erythropoietic protoporphyria.…Published: 27 October 2014
